Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$0.65 - $1.31 $2,340 - $4,716
3,600 New
3,600 $3,000
Q2 2022

Aug 11, 2022

SELL
$0.7 - $1.4 $114,093 - $228,187
-162,991 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$0.63 - $1.59 $158,637 - $400,371
-251,806 Reduced 60.71%
162,991 $210,000
Q4 2021

Feb 10, 2022

BUY
$1.27 - $2.42 $13,028 - $24,826
10,259 Added 2.54%
414,797 $527,000
Q3 2021

Nov 12, 2021

SELL
$2.15 - $3.82 $98,925 - $175,765
-46,012 Reduced 10.21%
404,538 $882,000
Q2 2021

Aug 05, 2021

SELL
$2.89 - $4.45 $154,236 - $237,492
-53,369 Reduced 10.59%
450,550 $1.69 Million
Q1 2021

May 06, 2021

BUY
$2.9 - $4.09 $33,176 - $46,789
11,440 Added 2.32%
503,919 $1.64 Million
Q4 2020

Feb 10, 2021

BUY
$3.38 - $5.14 $220,565 - $335,415
65,256 Added 15.27%
492,479 $1.68 Million
Q3 2020

Nov 12, 2020

BUY
$2.99 - $4.9 $123,319 - $202,095
41,244 Added 10.69%
427,223 $1.74 Million
Q2 2020

Aug 13, 2020

BUY
$2.11 - $3.38 $16,795 - $26,904
7,960 Added 2.11%
385,979 $1.31 Million
Q1 2020

May 06, 2020

BUY
$1.83 - $3.45 $33,558 - $63,266
18,338 Added 5.1%
378,019 $881,000
Q4 2019

Feb 05, 2020

BUY
$3.5 - $10.35 $83,041 - $245,564
23,726 Added 7.06%
359,681 $1.31 Million
Q3 2019

Oct 23, 2019

BUY
$7.03 - $9.7 $128,395 - $177,160
18,264 Added 5.75%
335,955 $2.79 Million
Q2 2019

Aug 14, 2019

BUY
$7.36 - $11.26 $162,619 - $248,789
22,095 Added 7.47%
317,691 $2.74 Million
Q1 2019

May 01, 2019

BUY
$9.08 - $11.84 $53,308 - $69,512
5,871 Added 2.03%
295,596 $3.16 Million
Q4 2018

Jan 31, 2019

BUY
$6.39 - $16.99 $360,849 - $959,442
56,471 Added 24.21%
289,725 $2.54 Million
Q3 2018

Nov 07, 2018

BUY
$16.52 - $24.82 $39,152 - $58,823
2,370 Added 1.03%
233,254 $3.92 Million
Q2 2018

Aug 06, 2018

BUY
$14.31 - $21.75 $197,649 - $300,411
13,812 Added 6.36%
230,884 $4.84 Million
Q1 2018

May 02, 2018

BUY
$16.09 - $23.07 $103,458 - $148,340
6,430 Added 3.05%
217,072 $3.49 Million
Q4 2017

Feb 09, 2018

BUY
$13.36 - $20.73 $624,686 - $969,293
46,758 Added 28.53%
210,642 $3.99 Million
Q3 2017

Nov 06, 2017

BUY
$8.75 - $14.07 $1.43 Million - $2.31 Million
163,884
163,884 $2.31 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.